Literature DB >> 27212422

Stevens-Johnson syndrome-like erosive dermatitis possibly related to afatinib.

Yuki Honda1, Yukari Hattori1, Satoshi Katsura1, Tsuyoshi Terashima2, Toshiaki Manabe2, Atsushi Otsuka3, Yoshiki Miyachi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27212422     DOI： 10.1684/ejd.2016.2807

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  6 in total

1.  Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient.

Authors:  Shaoyu Yang; Liming Wu; Xin Li; Jie Huang; Jianbo Zhong; Xueqin Chen
Journal:  Mol Clin Oncol       Date:  2018-01-11

Review 2.  Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Authors:  Emily L Coleman; Brianna Olamiju; Jonathan S Leventhal
Journal:  Oncol Rep       Date:  2020-12-24       Impact factor: 3.906

Review 3.  Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.

Authors:  Chau Yee Ng; Chun-Bing Chen; Ming-Ying Wu; Jennifer Wu; Chih-Hsun Yang; Rosaline Chung-Yee Hui; Ya-Ching Chang; Chun-Wei Lu
Journal:  J Immunol Res       Date:  2018-01-17       Impact factor: 4.818

Review 4.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

Review 5.  Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies.

Authors:  Yanping Li; Ruoqiu Fu; Tingting Jiang; Dongyu Duan; Yuanlin Wu; Chen Li; Ziwei Li; Rui Ni; Li Li; Yao Liu
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

6.  The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy.

Authors:  Ruofei Du; Huashan Yang; Huiyue Zhou; Lixia Ma; Mikiyas Amare Getu; Changying Chen; Tao Wang
Journal:  BMC Cancer       Date:  2022-05-03       Impact factor: 4.638
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.